Global Roxithromycin API Market Research Report 2024

Publication ID:

PB506250340

Publication Date:

June 27, 2024

Pages:

104

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Specialty Chemicals [2]

Manufacturing (Chemicals) [3]

Chemicals [4]

Description:

Roxithromycin(CAS锛�80214-83-1) is a semi-synthetic macrolide antibiotic. It is used to treat respiratory tract, urinary and soft tissue infections.
The global Roxithromycin API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Roxithromycin API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Roxithromycin API.
Report Scope
The Roxithromycin API market size, estimations, and forecasts are provided in terms of output/shipments (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Roxithromycin API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Roxithromycin API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Otto Brandes
Beijing Mesochem Technology
Century Pharmaceuticals
Octavius Pharma Pvt. Ltd
HEC Pharm
Kopran
Alembic Pharmaceuticals Limited
Envee Drugs
Zhejiang Zhenyuan Pharmaceutical
Huangshi Shixing Pharmaceutical
Hanways Chempharm Co., Limited
Segment by Type
Above 98 %
Above 99 %
Segment by Application
Tablets
Capsules
Granules
Others
Production by Region
Europe
China
India
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Roxithromycin API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Roxithromycin API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Roxithromycin API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Roxithromycin API Market Overview
1.1 Product Definition
1.2 Roxithromycin API Segment by Type
1.2.1 Global Roxithromycin API Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Above 98 %
1.2.3 Above 99 %
1.3 Roxithromycin API Segment by Application
1.3.1 Global Roxithromycin API Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Tablets
1.3.3 Capsules
1.3.4 Granules
1.3.5 Others
1.4 Global Market Growth Prospects
1.4.1 Global Roxithromycin API Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Roxithromycin API Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Roxithromycin API Production Estimates and Forecasts (2019-2030)
1.4.4 Global Roxithromycin API Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Roxithromycin API Production Market Share by Manufacturers (2019-2024)
2.2 Global Roxithromycin API Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Roxithromycin API, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Roxithromycin API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Roxithromycin API Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Roxithromycin API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Roxithromycin API, Product Offered and Application
2.8 Global Key Manufacturers of Roxithromycin API, Date of Enter into This Industry
2.9 Roxithromycin API Market Competitive Situation and Trends
2.9.1 Roxithromycin API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Roxithromycin API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Roxithromycin API Production by Region
3.1 Global Roxithromycin API Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Roxithromycin API Production Value by Region (2019-2030)
3.2.1 Global Roxithromycin API Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Roxithromycin API by Region (2025-2030)
3.3 Global Roxithromycin API Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Roxithromycin API Production by Region (2019-2030)
3.4.1 Global Roxithromycin API Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Roxithromycin API by Region (2025-2030)
3.5 Global Roxithromycin API Market Price Analysis by Region (2019-2024)
3.6 Global Roxithromycin API Production and Value, Year-over-Year Growth
3.6.1 Europe Roxithromycin API Production Value Estimates and Forecasts (2019-2030)
3.6.2 China Roxithromycin API Production Value Estimates and Forecasts (2019-2030)
3.6.3 India Roxithromycin API Production Value Estimates and Forecasts (2019-2030)
4 Roxithromycin API Consumption by Region
4.1 Global Roxithromycin API Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Roxithromycin API Consumption by Region (2019-2030)
4.2.1 Global Roxithromycin API Consumption by Region (2019-2024)
4.2.2 Global Roxithromycin API Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Roxithromycin API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Roxithromycin API Consumption by Country (2019-2030)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Roxithromycin API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Roxithromycin API Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Roxithromycin API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Roxithromycin API Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Roxithromycin API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Roxithromycin API Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Roxithromycin API Production by Type (2019-2030)
5.1.1 Global Roxithromycin API Production by Type (2019-2024)
5.1.2 Global Roxithromycin API Production by Type (2025-2030)
5.1.3 Global Roxithromycin API Production Market Share by Type (2019-2030)
5.2 Global Roxithromycin API Production Value by Type (2019-2030)
5.2.1 Global Roxithromycin API Production Value by Type (2019-2024)
5.2.2 Global Roxithromycin API Production Value by Type (2025-2030)
5.2.3 Global Roxithromycin API Production Value Market Share by Type (2019-2030)
5.3 Global Roxithromycin API Price by Type (2019-2030)
6 Segment by Application
6.1 Global Roxithromycin API Production by Application (2019-2030)
6.1.1 Global Roxithromycin API Production by Application (2019-2024)
6.1.2 Global Roxithromycin API Production by Application (2025-2030)
6.1.3 Global Roxithromycin API Production Market Share by Application (2019-2030)
6.2 Global Roxithromycin API Production Value by Application (2019-2030)
6.2.1 Global Roxithromycin API Production Value by Application (2019-2024)
6.2.2 Global Roxithromycin API Production Value by Application (2025-2030)
6.2.3 Global Roxithromycin API Production Value Market Share by Application (2019-2030)
6.3 Global Roxithromycin API Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Otto Brandes
7.1.1 Otto Brandes Roxithromycin API Corporation Information
7.1.2 Otto Brandes Roxithromycin API Product Portfolio
7.1.3 Otto Brandes Roxithromycin API Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Otto Brandes Main Business and Markets Served
7.1.5 Otto Brandes Recent Developments/Updates
7.2 Beijing Mesochem Technology
7.2.1 Beijing Mesochem Technology Roxithromycin API Corporation Information
7.2.2 Beijing Mesochem Technology Roxithromycin API Product Portfolio
7.2.3 Beijing Mesochem Technology Roxithromycin API Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Beijing Mesochem Technology Main Business and Markets Served
7.2.5 Beijing Mesochem Technology Recent Developments/Updates
7.3 Century Pharmaceuticals
7.3.1 Century Pharmaceuticals Roxithromycin API Corporation Information
7.3.2 Century Pharmaceuticals Roxithromycin API Product Portfolio
7.3.3 Century Pharmaceuticals Roxithromycin API Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Century Pharmaceuticals Main Business and Markets Served
7.3.5 Century Pharmaceuticals Recent Developments/Updates
7.4 Octavius Pharma Pvt. Ltd
7.4.1 Octavius Pharma Pvt. Ltd Roxithromycin API Corporation Information
7.4.2 Octavius Pharma Pvt. Ltd Roxithromycin API Product Portfolio
7.4.3 Octavius Pharma Pvt. Ltd Roxithromycin API Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Octavius Pharma Pvt. Ltd Main Business and Markets Served
7.4.5 Octavius Pharma Pvt. Ltd Recent Developments/Updates
7.5 HEC Pharm
7.5.1 HEC Pharm Roxithromycin API Corporation Information
7.5.2 HEC Pharm Roxithromycin API Product Portfolio
7.5.3 HEC Pharm Roxithromycin API Production, Value, Price and Gross Margin (2019-2024)
7.5.4 HEC Pharm Main Business and Markets Served
7.5.5 HEC Pharm Recent Developments/Updates
7.6 Kopran
7.6.1 Kopran Roxithromycin API Corporation Information
7.6.2 Kopran Roxithromycin API Product Portfolio
7.6.3 Kopran Roxithromycin API Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Kopran Main Business and Markets Served
7.6.5 Kopran Recent Developments/Updates
7.7 Alembic Pharmaceuticals Limited
7.7.1 Alembic Pharmaceuticals Limited Roxithromycin API Corporation Information
7.7.2 Alembic Pharmaceuticals Limited Roxithromycin API Product Portfolio
7.7.3 Alembic Pharmaceuticals Limited Roxithromycin API Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Alembic Pharmaceuticals Limited Main Business and Markets Served
7.7.5 Alembic Pharmaceuticals Limited Recent Developments/Updates
7.8 Envee Drugs
7.8.1 Envee Drugs Roxithromycin API Corporation Information
7.8.2 Envee Drugs Roxithromycin API Product Portfolio
7.8.3 Envee Drugs Roxithromycin API Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Envee Drugs Main Business and Markets Served
7.7.5 Envee Drugs Recent Developments/Updates
7.9 Zhejiang Zhenyuan Pharmaceutical
7.9.1 Zhejiang Zhenyuan Pharmaceutical Roxithromycin API Corporation Information
7.9.2 Zhejiang Zhenyuan Pharmaceutical Roxithromycin API Product Portfolio
7.9.3 Zhejiang Zhenyuan Pharmaceutical Roxithromycin API Production, Value, Price and Gross Margin (2019-2024)
7.9.4 Zhejiang Zhenyuan Pharmaceutical Main Business and Markets Served
7.9.5 Zhejiang Zhenyuan Pharmaceutical Recent Developments/Updates
7.10 Huangshi Shixing Pharmaceutical
7.10.1 Huangshi Shixing Pharmaceutical Roxithromycin API Corporation Information
7.10.2 Huangshi Shixing Pharmaceutical Roxithromycin API Product Portfolio
7.10.3 Huangshi Shixing Pharmaceutical Roxithromycin API Production, Value, Price and Gross Margin (2019-2024)
7.10.4 Huangshi Shixing Pharmaceutical Main Business and Markets Served
7.10.5 Huangshi Shixing Pharmaceutical Recent Developments/Updates
7.11 Hanways Chempharm Co., Limited
7.11.1 Hanways Chempharm Co., Limited Roxithromycin API Corporation Information
7.11.2 Hanways Chempharm Co., Limited Roxithromycin API Product Portfolio
7.11.3 Hanways Chempharm Co., Limited Roxithromycin API Production, Value, Price and Gross Margin (2019-2024)
7.11.4 Hanways Chempharm Co., Limited Main Business and Markets Served
7.11.5 Hanways Chempharm Co., Limited Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Roxithromycin API Industry Chain Analysis
8.2 Roxithromycin API Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Roxithromycin API Production Mode & Process
8.4 Roxithromycin API Sales and Marketing
8.4.1 Roxithromycin API Sales Channels
8.4.2 Roxithromycin API Distributors
8.5 Roxithromycin API Customers
9 Roxithromycin API Market Dynamics
9.1 Roxithromycin API Industry Trends
9.2 Roxithromycin API Market Drivers
9.3 Roxithromycin API Market Challenges
9.4 Roxithromycin API Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer

Companies Mentioned:

Otto Brandes
Beijing Mesochem Technology
Century Pharmaceuticals
Octavius Pharma Pvt. Ltd
HEC Pharm
Kopran
Alembic Pharmaceuticals Limited
Envee Drugs
Zhejiang Zhenyuan Pharmaceutical
Huangshi Shixing Pharmaceutical
Hanways Chempharm Co., Limited

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂